These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 29414277)

  • 61. Prompt diagnosis and management of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder and hemophagocytosis: A dreaded complication in a post-liver transplant child.
    Jha B; Mohan N; Gajendra S; Sachdev R; Goel S; Sahni T; Raina V; Soin A
    Pediatr Transplant; 2015 Nov; 19(7):E177-80. PubMed ID: 26184957
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.
    San-Juan R; Comoli P; Caillard S; Moulin B; Hirsch HH; Meylan P;
    Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():109-18. PubMed ID: 24475976
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells.
    Haque T; Wilkie GM; Taylor C; Amlot PL; Murad P; Iley A; Dombagoda D; Britton KM; Swerdlow AJ; Crawford DH
    Lancet; 2002 Aug; 360(9331):436-42. PubMed ID: 12241714
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Posttransplantation lymphoproliferative disease: proposed imaging classification.
    Camacho JC; Moreno CC; Harri PA; Aguirre DA; Torres WE; Mittal PK
    Radiographics; 2014; 34(7):2025-38. PubMed ID: 25384299
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.
    Taylor AL; Marcus R; Bradley JA
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):155-67. PubMed ID: 15979320
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.
    Kinch A; Oberg G; Arvidson J; Falk KI; Linde A; Pauksens K
    Scand J Infect Dis; 2007; 39(3):235-44. PubMed ID: 17366054
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.
    Ueda K; Ikeda K; Ogawa K; Sukegawa M; Sano T; Kimura S; Suzuki O; Hashimoto Y; Takeishi Y
    J Med Case Rep; 2016 Aug; 10(1):236. PubMed ID: 27557810
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Endoscopic diagnosis of lymphoproliferative disease after solid organ transplantation.
    Kocoshis SA
    J Pediatr Gastroenterol Nutr; 1999 Apr; 28(4):375-6. PubMed ID: 10204499
    [No Abstract]   [Full Text] [Related]  

  • 69. Post-transplant lymphoproliferative disorder.
    Loren AW; Tsai DE
    Clin Chest Med; 2005 Dec; 26(4):631-45, vii. PubMed ID: 16263402
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Prevention, diagnosis, and treatment of viral infections in patients with hematologic diseases].
    Kimura H
    Rinsho Ketsueki; 2007 Apr; 48(4):285-90. PubMed ID: 17515118
    [No Abstract]   [Full Text] [Related]  

  • 71. [Post-transplant lymphoproliferative disorders in renal transplantation: two decades of experience].
    Franco A; Jiménez L; Sillero C; Trigueros M; González D; Alcaraz E; Olivares J
    Nefrologia; 2010; 30(6):669-75. PubMed ID: 21113217
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Calcineurin inhibitor-free graft-versus-host disease prophylaxis with sirolimus and mycophenolate mofetil in a second allogeneic stem cell transplantation for engraftment failure and rituximab-refractory Epstein-Barr virus-induced posttransplant lymphoproliferative disease.
    Ceppi F; Duval M; Teira P; Therrien R; Ovetchkine P; Mallette B; Bittencourt H
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):e319-21. PubMed ID: 24977404
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Lymphoproliferative disorders after liver transplantation].
    Pageaux GP
    Gastroenterol Clin Biol; 2001 Apr; 25(4):357-66. PubMed ID: 11449124
    [No Abstract]   [Full Text] [Related]  

  • 74. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S; Zafar MN; Best J; Reddy HK
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Management of lymphoproliferative disorders associated to organ transplantation].
    Segura Huerta A; Gómez Codina J
    Med Clin (Barc); 2003 May; 120(20):780-5. PubMed ID: 12797932
    [No Abstract]   [Full Text] [Related]  

  • 76. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
    Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
    J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [The efficacy and safety of donor lymphocyte infusion to treat Epstein-Barr virus associated lymphoproliferative diseases after allogeneic hematopoietic stem cell transplantation].
    Xu LP; Liu DH; Liu KY; Chen H; Han W; Wang Y; Wang J; Shi HX; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2010 Nov; 49(11):955-8. PubMed ID: 21211211
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Epstein-Barr virus infection and lymphoproliferative disorder after hematopoietic cell transplantation.
    Zhong Y
    Clin J Oncol Nurs; 2012 Apr; 16(2):211-4. PubMed ID: 22459531
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Rituximab monotherapy following surgical resection of gastrointestinal post-transplant lymphoproliferative disorder in solid organ transplant recipients.
    Puckrin R; Peters A
    Clin Transplant; 2023 Feb; 37(2):e14910. PubMed ID: 36629389
    [No Abstract]   [Full Text] [Related]  

  • 80. Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
    Zhu KE; Li JP; Zhang T; Zhong J; Chen J
    Hematology; 2007 Apr; 12(2):117-21. PubMed ID: 17454192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.